Novartis Institutes for BioMedical Research



Novartis Institutes for BioMedical Research

NIBR takes a unique approach to pharmaceutical research. At the earliest stages, patient need and disease understanding determine research priorities. NIBR depends on thousands of dedicated and talented people to discover and develop new and innovative medicines. Innovation is enhanced by a diversity of opinions, perspectives and ideas from people with different cultural backgrounds and professional experiences. On any given day, at any given moment, our scientists are working hard at nine research institutes around the world to bring innovative medicines to patients.The Global Discovery Chemistry (GDC) Platform is at the center of drug discovery research at NIBR, focusing on the design and synthesis of potential drug molecules. Spanning several disciplines from computational and experimental chemistry to automation and robotics, researchers work in teams to study these new molecules and select those that have the greatest potential to help patients.The Disease Area chemistry units work in close collaboration with the disease experts on early-stage discovery projects from the synthesis and testing, to the ultimate selection of a drug candidate.


Medicinal Chemistry, Chemistry. uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X